salvinorin a has been researched along with Brain Injuries in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, C; Hu, Q; Liu, R; Lu, J; Sun, J; Yang, X; Zhang, W; Zhang, Y; Zhou, C | 1 |
| He, Z; Wang, Z; Xin, J; Zhang, Y | 1 |
2 other study(ies) available for salvinorin a and Brain Injuries
| Article | Year |
|---|---|
Salvinorin A attenuates early brain injury through PI3K/Akt pathway after subarachnoid hemorrhage in rat.
Topics: Animals; Apoptosis; Brain; Brain Edema; Brain Injuries; CA1 Region, Hippocampal; China; Diterpenes, Clerodane; Male; Neurons; Neuroprotective Agents; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction; Subarachnoid Hemorrhage | 2019 |
Highly selective non-opioid kappa opioid receptor (KOR) agonist salvinorin A protects against forebrain ischemia-induced brain injury in rats.
Topics: Animals; Aquaporin 4; Brain Injuries; Brain Ischemia; Cognition; Disease Models, Animal; Diterpenes, Clerodane; Male; Neuroprotective Agents; Prosencephalon; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Reperfusion Injury | 2016 |